|
[1]
|
Wu XL, Ye ZJ, Xie X, Huang F, Kong DF, Feng TJ, et al. Based on a Markov model, cost-effectiveness analysis of influenza vaccination among people aged 60 years and older in Shenzhen. Chin J Epidemiol 2022;43(7):1140 − 6.CrossRef
|
|
[2]
|
Yang J, Atkins KE, Feng LZ, Baguelin M, Wu P, Yan H, et al. Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis. BMC Med 2020;18(1):90.CrossRef
|
|
[3]
|
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG. Technical guidelines for seasonal influenza vaccination in China (2023-2024). Chin J Epidemiol 2023;44(10):1507 − 30.CrossRef
|
|
[4]
|
Wang YJ, Wang P, Zhang SD, Pan H. Uncertainty modeling of a modified SEIR epidemic model for COVID-19. Biology (Basel) 2022;11(8):1157.CrossRef
|
|
[5]
|
Bednarski S, Cowen LLE, Ma JL, Philippsen T, van den Driessche P, Wang MT. A contact tracing SIR model for randomly mixed populations. J Biol Dyn 2022;16(1):859 − 79.CrossRef
|
|
[6]
|
Zhao ZY, Zhou Y, Guan JX, Yan Y, Zhao J, Peng ZH, et al. The relationship between compartment models and their stochastic counterparts: a comparative study with examples of the COVID-19 epidemic modeling. J Biomed Res 2024;38(2):175 − 88.CrossRef
|
|
[7]
|
National Bureau of Statistics of China. China statistical yearbook 2023. Beijing: China Statistics Press. 2023. https://book.kongfz.com/434397/6853349509. (In Chinese). |
|
[8]
|
Yang J, Jit M, Zheng YM, Feng LZ, Liu XX, Wu JT, et al. The impact of influenza on the health related quality of life in China: an EQ-5D survey. BMC Infect Dis 2017;17(1):686.CrossRef
|
|
[9]
|
You XY, Zhang YL, Zeng JF, Wang CJ, Sun HP, Ma QH, et al. Disparity of the Chinese elderly’s health-related quality of life between urban and rural areas: a mediation analysis. BMJ Open 2019;9(1):e024080.CrossRef
|
|
[10]
|
Yang J, Jit M, Leung KS, Zheng YM, Feng LZ, Wang LP, et al. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey. Infect Dis Poverty 2015;4:44.CrossRef
|
|
[11]
|
Yue XM, Li YX, Wu JH, Guo JJ. Current development and practice of pharmacoeconomic evaluation guidelines for universal health coverage in China. Value Health Reg Issues 2021;24:1 − 5.CrossRef
|
|
[12]
|
Wang Q, Yue N, Zheng MY, Wang DL, Duan CX, Yu XG, et al. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: a meta-analysis. Vaccine 2018;36(48):7262 − 9.CrossRef
|
|
[13]
|
Molinari NAM, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007;25(27):5086 − 96.CrossRef
|
|
[14]
|
Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2018;2(2):CD004879.CrossRef
|
|
[15]
|
Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2018;2(2):CD001269.CrossRef
|